Application of fFN and CRP in the evaluation of therapeutic effect for preterm labor

Select 106 pregnant women with threatened preterm labor between 28 and 37 weeks of gestation. They have been treated continually by the preventing preterm labor therapy including antibiotics and magnesium sulfate. Cervicovaginal fetal fibronectin (fFN) and C-reactive protein (CRP) in serum were dete...

Full description

Saved in:
Bibliographic Details
Published inZhongguo yi liao qi xie za zhi Vol. 39; no. 1; p. 77
Main Author Li, Rui
Format Journal Article
LanguageChinese
Published China 01.01.2015
Subjects
C-Reactive Protein - analysis
Female
Fibronectins - blood
Humans
Infant, Newborn
Obstetric Labor, Premature - diagnosis
Obstetric Labor, Premature - prevention & control
Pregnancy
Online AccessGet more information

Cover

More Information
Summary:Select 106 pregnant women with threatened preterm labor between 28 and 37 weeks of gestation. They have been treated continually by the preventing preterm labor therapy including antibiotics and magnesium sulfate. Cervicovaginal fetal fibronectin (fFN) and C-reactive protein (CRP) in serum were detected before treatment and after 3-day and 7-day treatment respectively. 100 normal pregnant women were included as control group. (1) The fFN and CRP had significant differences between study group and control group (P<0.05). (2) The fFN and CPR were different compared in the treatment period (P<0.05). Fetal fibronectin and CRP can be used can be used in therapeutic effect evaluation of threatened preterm labor.
ISSN:1671-7104